MedPath

天津武田药品有限公司

Ownership
-
Established
1994-03-08
Employees
-
Market Cap
-
Website
takeda-tj.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

NMPA:8

Drug Approvals

Lansoprazole Enteric Capsules

Product Name
达克普隆
Approval Number
国药准字H10980035
Approval Date
Jan 7, 2020
NMPA

Lansoprazole Enteric Capsules

Product Name
达克普隆
Approval Number
国药准字H10980036
Approval Date
Jan 7, 2020
NMPA

Voglibose Tablets

Product Name
倍欣
Approval Number
国药准字H20163151
Approval Date
Sep 9, 2019
NMPA

Voglibose Tablets

Product Name
倍欣
Approval Number
国药准字H20010308
Approval Date
Sep 9, 2019
NMPA

Candesartan Cilexetil Tablets

Product Name
坎地沙坦酯片
Approval Number
国药准字H20083223
Approval Date
Nov 15, 2017
NMPA

Candesartan Cilexetil Tablets

Product Name
坎地沙坦酯片
Approval Number
国药准字H20103244
Approval Date
Apr 30, 2015
NMPA

Serrapeptase Tablets

Product Name
舍雷肽酶片
Approval Number
国药准字H20000042
Approval Date
Aug 31, 2010
NMPA

Pioglitazone Hydrochloride Tablets

Product Name
盐酸吡格列酮片
Approval Number
国药准字H20080192
Approval Date
Apr 3, 2008
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.